Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually

Bone Marrow Transplantation

Volumn 51, Issue 6, 2016, Pages 786-792

  Passweg, J R ^a   Baldomero, H ^a   Bader, P ^b   Bonini, C ^c   Cesaro, S ^d   Dreger, P ^e   Duarte, R F ^f   Dufour, C ^g   Kuball, J ^h   Farge Bancel, D ⁱ   Gennery, A ^j   Kroger, N ^k   Lanza, F ^l   Nagler, A ^m   Sureda, A ^f   Mohty, M ⁿ  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d Paediatric Haematology Oncology   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f HOSPITAL DURAN I REYNALS   (Spain)

^g G GASLINI INSTITUTE   (Italy)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l Hematology and BMT Unit   (Italy)

^m SHEBA MEDICAL CENTER   (Israel)

ⁿ HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; AMYLOIDOSIS; APLASTIC ANEMIA; AUTOTRANSPLANTATION; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; EUROPE; HAPLOIDENTICAL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTICENTER STUDY; NEOPLASM; PATIENT CARE; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

AMYLOIDOSIS; ANEMIA, APLASTIC; CORD BLOOD STEM CELL TRANSPLANTATION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; PATIENT CARE TEAM; SURVEYS AND QUESTIONNAIRES; TISSUE DONORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HAPLOIDENTICAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 84959116459     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2016.20     Document Type: Article

References (19)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475.
3. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219-234.
4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
5. Alois G, Marcelo CP, Mahmoud A, Yoshiko A, Helen B, Lydia F et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol 2015; 2: e91-e100.
6. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191.
7. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
8. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
9. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
10. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637-643.
11. Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014; 49: 744-750.
12. Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50: 476-482.
13. World Health Organisation, WHO (http://www.who.int/topics/transplantation/en/).
14. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811-818.
15. Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J et al. Blood and Marrow Transplant Clinical Trials Network. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011; 118: 282-288.
16. Luznik L, O'Donnell PV, Symons, Chen AR, Leffell MS, Zahurak M et al. HLAhaploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641-650.
17. Ballen KK, Verter F, Kurtzberg J. Umbilical cord blood donation: public or private? Bone Marrow Transplant 2015; 50: 1271-1278.
18. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-923.
19. Anita D'Souza, Angela D, Baldeep W, Mei-Jie Z, Jiaxing H, Morie AG et al. Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for International blood and marrow transplant research study. J Clin Oncol 2015; 33: 3741-3749.